Table 5 Demographics and clinical characteristics in patient who underwent gastric ESD
From: The impact of face shields on the quality of gastrointestinal endoscopy during the COVID-19 pandemic
|  | Face shield (n = 72) | Non-face shield (n = 72) | P value |
|---|---|---|---|
Age, mean, years | 65.67 ± 9.30 | 67.35 ± 10.18 | 0.303 |
Gender, n | 0.835 | ||
 Male | 58 | 57 |  |
 Female | 14 | 15 |  |
Tumor size, mean ± SD, mm | 12.70 ± 7.21 | 14.89 ± 8.43 | 0.097 |
Location | 0.067 | ||
 Antrum | 46 | 56 |  |
 Body and fundus | 26 | 16 |  |
Macroscopic type | 0.943 | ||
 Elevated | 30 | 32 |  |
 Flat | 12 | 9 |  |
 Depressed | 21 | 24 |  |
 Mixed | 9 | 7 |  |
H.pylori status | 0.863 | ||
 Positive | 26 | 27 |  |
 Negative | 46 | 45 |  |
Final pathology | 0.165 | ||
 HGD | 21 | 12 |  |
 EGC, differentiated | 48 | 58 |  |
 EGC, undifferentiated | 3 | 2 |  |
Invasion depth | 0.574 | ||
 HGD and T1a | 66 | 64 |  |
 T1b and deeper | 6 | 8 |  |
Endoscopists | 0.688 | ||
 Endoscopist 1 | 57 | 55 |  |
 Endoscopist 2 | 15 | 17 |  |